Current stumbling blocks in oncology drug development.

Ernst Schering Research Foundation workshop

Volumn , Issue 59, 2007, Pages 135-149

  Gimmi, C D ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BIOLOGICAL MODEL; CHEMISTRY; CLINICAL TRIAL; DRUG DESIGN; DRUG INDUSTRY; DRUG SCREENING; HUMAN; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); ONCOLOGY; PHARMACEUTICS; REVIEW;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS; DRUG DESIGN; DRUG INDUSTRY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; TECHNOLOGY, PHARMACEUTICAL;

EID: 39049188312     PISSN: 09476075     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-540-49529-1_10     Document Type: Review

References (25)